Clinical trials
Completed trials in Guatemala
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
301 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 7 |
| 2003 | 10 |
| 2004 | 9 |
| 2005 | 10 |
| 2006 | 14 |
| 2007 | 7 |
| 2008 | 22 |
| 2009 | 23 |
| 2010 | 23 |
| 2011 | 21 |
| 2012 | 23 |
| 2013 | 14 |
| 2014 | 15 |
| 2015 | 13 |
| 2016 | 8 |
| 2017 | 13 |
| 2018 | 11 |
| 2019 | 13 |
| 2020 | 13 |
| 2021 | 7 |
| 2022 | 10 |
| 2023 | 6 |
| 2024 | 4 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 301 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 53 |
| Hoffmann-La Roche | 39 |
| Merck Sharp & Dohme LLC | 20 |
| Sanofi | 15 |
| Boehringer Ingelheim | 13 |
| Takeda | 13 |
| NICHD Global Network for Women's and Children's Health | 12 |
| University of Colorado, Denver | 10 |
| Novartis | 8 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 8 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 43 |
| Arthritis, Rheumatoid | 15 |
| Breast Neoplasms | 15 |
| Hypertension | 14 |
| Asthma | 12 |
| Diabetes Mellitus | 12 |
| Pulmonary Disease, Chronic Obstructive | 10 |
| Dyslipidemias | 9 |
| Glucose Metabolism Disorders | 9 |
| Stomach Neoplasms | 9 |
Trials
Showing 76 to 100 of 301. Each trial links to its page on Pharma Observatory.
201 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.